Michael H. Davidson - 09 Oct 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Executive Officer, Director
Signature
/s/ Michael H. Davidson
Issuer symbol
NAMS
Transactions as of
09 Oct 2024
Transactions value $
-$172,500
Form type
4
Filing time
11 Oct 2024, 17:01:08 UTC
Previous filing
25 Sep 2024
Next filing
12 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAMS Warrant (right to buy) Gift -$173K -15K -15% $11.50 85K 09 Oct 2024 Ordinary Shares 15K $11.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.